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ABSTRACT: Antifreeze glycoproteins (AFGPs) from
polar ﬁsh are the most potent ice recrystallization (growth)
inhibitors known, and synthetic mimics are required for
low-temperature applications such as cell cryopreservation.
Here we introduce facially amphipathic glycopolymers that
mimic the three-dimensional structure of AFGPs. Glyco-
polymers featuring segregated hydrophilic and hydro-
phobic faces were prepared by ring-opening metathesis
polymerization, and their rigid conformation was con-
ﬁrmed by small-angle neutron scattering. Ice recrystalliza-
tion inhibition (IRI) activity was reduced when a
hydrophilic oxo-ether was installed on the glycan-opposing
face, but signiﬁcant activity was restored by incorporating a
hydrophobic dimethylfulvene residue. This biomimetic
strategy demonstrates that segregated domains of distinct
hydrophilicity/hydrophobicity are a crucial motif to
introduce IRI activity, which increases our understanding
of the complex ice crystal inhibition processes.
Antifreeze glycoproteins (AFGPs) are found in the tissuesand blood serum of extremophile ﬁsh species and act to
modulate the growth of extracellular ice.1 A key property of
AFGPs is ice recrystallization inhibition (IRI), which slows ice
crystal growth (distinct from nucleation2).3 Ice recrystallization
is a major cause of cell death during the freezing of cells and
tissue for transfusion, fundamental biomedicine, and cell
biology. Hence, AFGPs (or their mimics) have many potential
applications.4 Cryopreservation with AFGPs (and non-glyco-
sylated antifreeze proteins, AFPs)5 is limited, however, by their
secondary property of dynamic ice shaping, whereby the
AFGPs shape the ice into needle-like (spicular) morphologies,
which can pierce cell membranes.3 AFGPs are also challenging
to synthesize, requiring multistep procedures.6,7 Gibson and co-
workers have developed synthetic polymers8,9 based upon
poly(vinyl alcohol) and poly(ampholytes) which have been
found to enhance the cryopreservation of blood10−12 and
nucleated cells.4,13
In the case of AFPs, deﬁned ice-binding faces have been
identiﬁed using structural biology methods.14 Conversely, there
is no crystal structure available for AFGPs, and the exact
structural motifs required for IRI are unknown, although the
glycan unit is essential for ice shaping.7 Solution NMR studies
suggest that AFGPs form a polyproline II type of helix, with the
glycans on one face and peptides on the opposite, forming a
facially amphipathic structure.15 It is emerging that this
segregated display of hydrophobic/hydrophilic groups, rather
than a “binding site”, is the essential feature for IRI
activity.8,16,17 Molecular modeling recently revealed that the
hydrophobic face, not the glycans, of AFGPs interacts with the
ice, and that the spatial segregation along the polyproline II
helix is essential.18 Gibson and co-workers have shown that
homopolyproline has a weak IRI,4 and that self-assembled
metallohelicities with “patchy” amphipathy are potent IRIs,19
which supports a hypothesis that well-deﬁned ice-binding
domains are not essential for IRI.20 Amphipathy has also been
seen to be important in ice nucleation.21 This evidence suggests
that IRI, but not ice shaping,22 could be selectively introduced
into new and emerging (bio)materials, if precise control over
hydrophilic/hydrophobic domains is possible.
The design of polymers with solvent-exposed hydrophobic
domains is, however, nontrivial. Block copolymeric amphiphiles
spontaneously self-assemble into micelles/vesicles to reduce the
hydrophobic domain’s contact with water, and hence only
“water-loving” surfaces are exposed.23 Tew and co-workers have
developed facially amphipathic cationic polymers, with
opposing positive charges and lipophilic domains to mimic
the function of antimicrobial peptides.24,25 A crucial design step
was the use of ring-opening metathesis polymerization
(ROMP), which introduces rigid alkene backbones, while
balancing the hydrophobicity/hydrophilicity to maintain both
solubility and the presentation of hydrophobic faces. These
have shown particular potency as potential antimicrobials.26
Considering the above, we designed and synthesized locally
rigid, facially amphipathic glycopolymers. A combination of ice
binding assays, modeling, and small-angle neutron scattering
(SANS) provides compelling evidence that local amphipathy is
an essential motif for introducing IRI activity, providing design
rules for new materials to mimic AFGP function.
Figure 1A shows the solution-state structure of AFGP,7 with
the disaccharide units spatially segregated from the hydro-
phobic peptide backbone. Our approach was to use ROMP to
introduce local rigidity,27 in contrast to ﬂexible backbones
obtained from radical polymerization. Four monomers were
synthesized to give a range of amphipathies: M1 was prepared
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by acetylation of a commercial norbornenediol; M2 and M3
were synthesized by Koenigs−Knorr coupling of acetobromo-
α-D-galactose with exo,exo-[oxo/fulvene]norborneneimide; and
M4 was synthesized by substitution of monomethoxyhexa-
ethylene glycol monotosylate (Figure 1B). The hydrophilic
galactose and hydrophobic fulvene motifs were selected in
particular due to their intrinsic rigidities, giving monomers with
structurally distinct domains of opposing polarity. These
monomers were polymerized using Grubbs’s third-generation
catalyst, and acetate protecting groups were subsequently
removed by treatment with sodium methoxide followed by ion
exchange (Figure 1C). The panel of amphipathic polymers was
characterized by size-exclusion chromatography (SEC; Đ < 1.4)
and NMR (nuclear magnetic resonance) and IR (infrared)
spectroscopy (see Supporting Information (SI) and Table 1).
The polymer library was assessed for IRI activity using a
“splat” assay, where ice crystals are nucleated and their growth
after 30 min at −8 °C was recorded. Activity is expressed as the
mean grain area (MGA) relative to a phosphate-buﬀered saline
(PBS) control, with smaller values representing more activity.
Polymers derived from M2 containing the “fulvo” motif were
signiﬁcantly less soluble than those derived fromM3 containing
the “oxo”-ether units. Their solution concentrations were
therefore determined by UV−vis absorption spectroscopy (see
SI for Beer−Lambert plots) at saturation. In the case of
poly(Fulvo), 1% v/v dimethylsulfoxide was required, and
controls were adjusted to account for this.
Poly(Oxo) was found to inhibit ice crystal growth by ∼50%
MGA at concentrations above 5 mg·mL−1 (Figure 2A), which
makes it more active than many previously reported IRI-active
polymers.28,29 The poly(Fulvo) derivative featuring the hydro-
phobic face, however, was considerably more active, inhibiting
by ∼50% MGA at just 0.5 mg·mL−1 (solubility limit),
supporting the facially amphipathic hypothesis for IRI.
Molecular models corroborate this (Figure 2B) and illustrate
the relative increase in hydrophobicity across the poly(Oxo)
and poly(Fulvo) homopolymers. To improve the solubility, a
1:1 statistical copolymer of M2/M3, poly(Fulvo-co-Oxo), was
prepared. This co-polymer had signiﬁcantly improved solubility
and comparable overall IRI activity to poly(Fulvo), showing
that some co-monomer incorporation is tolerated, unlike
PVA,30 and example ice wafers are shown in Figure 2C.
However, the non-ideal copolymerization kinetics of the oxo
(M2) and fulvo (M3) co-monomers led to a blocky rather than
statistical copolymerization.31,32 Infrared analysis conﬁrmed
incomplete acetate removal (in contrast to the homopolymers),
suggesting an internalized domain structure and/or aggrega-
tion, with some (hydrophobic) surfaces being solvent
inaccessible and hence limiting the total activity of poly-
(Fulvo-co-Oxo). The monomers alone also had no activity (SI),
conﬁrming that a macromolecular architecture is essential.
To improve solubility, a norbornenediol monomer, M1, with
a non-hydrophilic bridgehead was investigated. De-acetylated
homopolymers of M1, poly(Diol), were found to have
surprisingly low solubility and no activity at their solubility
limit of 0.5 mg·mL−1. However, whenM1 was incorporated as a
co-monomer with the (IRI-active) “fulvo” monomerM2 to give
Figure 1. (A) Concept of facially amphipathic ROMP polymers to
mimic AFGP. Adapted from ref 7. (B,C) Monomers and polymers
synthesized here; hydrophilic groups are indicated in blue, and
hydrophobic in red.
Table 1. Polymer Characterization
Mn (g mol
−1)
theor exptla Đ (−)a DP (−)a conv (%)b
poly(Diol)c 10 000 2 200 1.01 14 100
5 300 1.01 34
8 400 1.02 54
poly(Fulvo) 25 000 10 300 1.21 28 100
poly(Oxo) 10 000 7 300 1.18 22 100
poly(FPEG) 10 000 35 900 1.38 133 100
poly(Fulvo-co-Diol)-11 5 000 10 700 1.12 14, 35 94/97
poly(Fulvo-co-Diol)-17 10 000 16 800 1.10 22, 54 100
poly(Fulvo-co-Diol)-35 25 000 34 600 1.26 47, 112 100
poly(Fulvo-co-Oxo) 10 000 7 700 1.35 11, 11 100/96
poly(Fulvo-co-FPEG) 10 000 55 600 1.47 76, 58 71
aMn = molar mass, Đ = dispersity, and DP = degree of polymerization, determined by SEC.
bConversion, determined by 1H NMR. cSingle species.
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poly(Fulvo-co-Diol), an overall increase in solubility was
achieved. Poly(Fulvo-co-Diol)-17 had remarkable IRI activity:
40% MGA at just 1.3 mg·mL−1 (Figure 3). This polymer
showed some molecular weight dependence on activity, with 17
kDa being more active than 11 kDa (and far more than the
monomer, indicating the need for a macromolecular
architecture). Increasing the molecular weight further to 35
kDa lowered the solubility of the copolymer, and hence the
activity, highlighting a “sweet spot”. Work undertaken by Inada
et al. described the molecular weight dependence on IRI of
PVA.33 Similarly, a previous study by Deswal et al. reported on
the IRI activity of proteins extracted from the leaves of the
freeze-tolerant plant Seabuckthorn, of which superior antifreeze
activity was observed only for polypeptides of elevated
molecular weights.34 Replacing the glycan with a short
oligo(ethylene glycol) PEG chain, to give both poly(Fulvo-co-
FPEG) and poly(FPEG), decreased activity, as the (ﬂexible)
PEG can access numerous conformations, reducing the overall
amphipathy (see SI). Hydrogenation of the alkene backbone to
increase ﬂexibility resulted in a wholly insoluble polymer (see
SI). These observations demonstrate that precise macro-
molecular engineering is essential to achieve a potent IRI
mimetic.
AF(G)Ps bind to speciﬁc ice crystal faces,35,36 leading to
dynamic ice shaping (unwanted in cryopreservation3). Control
ice crystals (Figure 4A) showed no dynamic ice shaping, but
addition of AFGPs (Figure 4B) produced distinctive spicular
(needle-like) crystals. Poly(Fulvo-co-Diol) (Figure 4C) did not
lead to ice shaping, ruling out strong and speciﬁc ice face
recognition and showing that these eﬀects can be separated by
macromolecular design.
SANS was employed to evaluate the solution conformation
and rigidity of the poly(Fulvo-co-Diol) series (Figure 5 and SI).
The persistence lengths, bt, were estimated from the position of
the characteristic crossover between the scattering proﬁle
typical for fractal aggregates (q−3.5) and that of rigid rods (q−1)
(see SI).37,38 The estimated bt values for poly(Fulvo-co-Diol)-
11 and poly(Fulvo-co-Diol)-17 are 38.9 and 44.4 Å,
respectively. It should be noted that the overlap may actually
occur at a lower q region, but is masked by aggregate scattering.
Thus, these values should be taken as the minimum persistence
length for each polymer. Nevertheless, each bt is much larger
Figure 2. (A) IRI activities of the poly(Fulvo), poly(Oxo), and
copolymer series. (B) Hydrophobic surface map of poly(Fulvo) and
poly(Oxo). (C,D) Optical microscopy of ice crystal wafers of PBS and
poly(Fulvo-co-Oxo).
Figure 3. IRI activities of the poly(Fulvo-co-Diol) molecular weight
series.
Figure 4. Optical microscopy ice morphology analysis: (A) water, −6
°C; (B) AFGP-8, −5 °C; (C) poly(Fulvo-co-Diol)-17 (0.72 mg·mL−1),
−8 °C.
Figure 5. SANS data for poly(Fulvo-co-Diol)-11 (1 mg.mL−1, red) and
poly(Fulvo-co-Diol)-17 (1 mg.mL−1, blue) in D2O at 25 °C. Straight
lines show −3.5 and −1 decays for comparison.
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than the monomer length (∼10 Å), which suggests that the
chain backbones are locally stiﬀ.38 Furthermore, given the
approximate contour length, L, of both polymer chains (490
and 760 Å for poly(Fulvo-co-Diol)-11 and poly(Fulvo-co-Diol)-
17, respectively), the large bt suggests rigid rather than highly
ﬂexible aggregates of potentially rod-like structures. This
rigidity, coupled with the intrinsic amphipathy of the polymers,
is aligned with the hypothesized semi-rigid (and generally
amphipathic) ice binding faces of AFPs,14,39 and the ﬂexible
hydrophilic “glycan face” of AFGPs, providing evidence that
facial amphipathy is a key motif for introducing IRI activity into
a diverse range of polymers.
To conclude, we have designed and synthesized facially
amphipathic glycopolymers to mimic the solution conﬁrmation
and selective functions of antifreeze glycoproteins. It was found
that the addition of hydrophobic faces, opposing the glycan
units, introduced potent IRI activity, but that substitution with
a more hydrophilic ether unit removed activity. These results
support a mechanism for IRI activity which is dependent upon
local water ordering rather than an essential ice binding unit,
and there was no evidence of dynamic ice shaping. Small-angle
neutron scattering supports a locally rigid conﬁrmation, as seen
for AF(G)Ps, supporting the hypothesis of amphipathy as the
driver for activity.
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